Ethics

European Union Advises Against Germline Therapy

Published in Gene Therapy Weekly, March 6th, 1995

The European Union advised that clinical experiments focused on making genetic changes inheritable should be banned.

An independent group issued the advice after spending 15 months studying the complex ethical implications and issues raised by biotechnological advances, reported European correspondent Rory Watson ("Europe Cautious over Genetics Trials," British Medical Journal, January 28, 1995;310:213-214).

Watson quoted the advisors as saying, "Because of the important controversial and unprecedented questions raised by germline therapy, and considering the actual state of the art, germline gene therapy on humans is not at the present time...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-03-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry